Ma C - Search Results

1

CDK4/6 inhibition reprograms the breast cancer enhancer landscape by stimulating AP-1 transcriptional activity.

Watt AC, Cejas P, DeCristo MJ, Metzger-Filho O, Lam EYN, Qiu X, BrinJones H, Kesten N, Coulson R, Font-Tello A, Lim K, Vadhi R, Daniels VW, Montero J, Taing L, Meyer CA, Gilan O, Bell CC, Korthauer KD, Giambartolomei C, Pasaniuc B, Seo JH, Freedman ML, Ma C, Ellis MJ, Krop I, Winer E, Letai A, Brown M, Dawson MA, Long HW, Zhao JJ, Goel S. Watt AC, et al. Among authors: ma c. Nat Cancer. 2021 Jan;2(1):34-48. doi: 10.1038/s43018-020-00135-y. Epub 2020 Nov 9. Nat Cancer. 2021. PMID: 33997789 Free PMC article.

2

Neoadjuvant endocrine therapy for locally advanced breast cancer.

Ma CX, Ellis MJ. Ma CX, et al. Semin Oncol. 2006 Dec;33(6):650-6. doi: 10.1053/j.seminoncol.2006.08.013. Semin Oncol. 2006. PMID: 17145344 Review.

3

Letrozole in the neoadjuvant setting: the P024 trial.

Ellis MJ, Ma C. Ellis MJ, et al. Among authors: ma c. Breast Cancer Res Treat. 2007;105 Suppl 1(Suppl 1):33-43. doi: 10.1007/s10549-007-9701-x. Epub 2007 Oct 3. Breast Cancer Res Treat. 2007. PMID: 17912634 Free PMC article. Clinical Trial.

4

Femara and the future: tailoring treatment and combination therapies with Femara.

Ellis M, Ma C. Ellis M, et al. Among authors: ma c. Breast Cancer Res Treat. 2007;105 Suppl 1(Suppl 1):105-15. doi: 10.1007/s10549-007-9697-2. Epub 2007 Oct 3. Breast Cancer Res Treat. 2007. PMID: 17912640 Free PMC article. Review.

5

Predicting endocrine therapy responsiveness in breast cancer.

Ma CX, Sanchez CG, Ellis MJ. Ma CX, et al. Oncology (Williston Park). 2009 Feb;23(2):133-42. Oncology (Williston Park). 2009. PMID: 19323294 Free article. Review.

6

Neoadjuvant endocrine therapy for breast cancer.

Chawla JS, Ma CX, Ellis MJ. Chawla JS, et al. Surg Oncol Clin N Am. 2010 Jul;19(3):627-38. doi: 10.1016/j.soc.2010.04.004. Surg Oncol Clin N Am. 2010. PMID: 20620931 Review.

7

Neoadjuvant endocrine therapy in primary breast cancer: indications and use as a research tool.

Chia YH, Ellis MJ, Ma CX. Chia YH, et al. Among authors: ma cx. Br J Cancer. 2010 Sep 7;103(6):759-64. doi: 10.1038/sj.bjc.6605845. Epub 2010 Aug 10. Br J Cancer. 2010. PMID: 20700118 Free PMC article. Review.

8

High prevalence of low vitamin D and musculoskeletal complaints in women with breast cancer.

Napoli N, Vattikuti S, Ma C, Rastelli A, Rayani A, Donepudi R, Asadfard M, Yarramaneni J, Ellis M, Armamento-Villareal R. Napoli N, et al. Among authors: ma c. Breast J. 2010 Nov-Dec;16(6):609-16. doi: 10.1111/j.1524-4741.2010.01012.x. Breast J. 2010. PMID: 21070438 Free PMC article.

9

Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer.

Sanchez CG, Ma CX, Crowder RJ, Guintoli T, Phommaly C, Gao F, Lin L, Ellis MJ. Sanchez CG, et al. Among authors: ma cx. Breast Cancer Res. 2011 Mar 1;13(2):R21. doi: 10.1186/bcr2833. Breast Cancer Res. 2011. PMID: 21362200 Free PMC article.

10

Importance of PI3-kinase pathway in response/resistance to aromatase inhibitors.

Ma CX, Crowder RJ, Ellis MJ. Ma CX, et al. Steroids. 2011 Jul;76(8):750-2. doi: 10.1016/j.steroids.2011.02.023. Epub 2011 Mar 21. Steroids. 2011. PMID: 21420991 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18,237 results

Search Page

Filters